AstraZeneca
🇬🇧United Kingdom
- Country
- 🇬🇧United Kingdom
- Ownership
- Public
- Employees
- 89.9K
- Market Cap
- $270.3B
- Website
- http://www.astrazeneca.co.uk
- Introduction
AstraZeneca Plc is a holding company, which engages in the research, development, manufacture, and commercialization of prescription medicines. The company was founded on June 17, 1992 and is headquartered in Cambridge, the United Kingdom.
A Study to Assess the Lung Exposure Bioequivalence of Budesonide, Glycopyrronium, & Formoterol (BGF) Metered Dose Inhaler (MDI) Hydrofluoroolefin (HFO) With a Spacer (Treatment B), BGF MDI Hydrofluoroalkane (HFA) With a Spacer (Treatment A), as Well as BGF MDI HFO Without a Spacer (Treatment C)
- First Posted Date
- 2024-04-01
- Last Posted Date
- 2024-07-05
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 132
- Registration Number
- NCT06340581
- Locations
- 🇩🇪
Research Site, Berlin, Germany
Transthyretin Amyloidosis Cardiomyopathy in Patients With HFpEF in Russia
Active, not recruiting
- Conditions
- First Posted Date
- 2024-04-01
- Last Posted Date
- 2024-07-16
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 1770
- Registration Number
- NCT06338839
- Locations
- 🇷🇺
Research Site, Yaroslavl, Russian Federation
Real-world Study on Dapagliflozin Usage in Patients With Heart Failure (HF) in Germany
Recruiting
- Conditions
- First Posted Date
- 2024-03-28
- Last Posted Date
- 2024-12-13
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 1000
- Registration Number
- NCT06336330
- Locations
- 🇩🇪
Research Site, Wermsdorf, Germany
A Study to Evaluate Cortisol Reserve in Response to Adrenocorticotropic Hormone (ACTH) Stimulation Test Following Baxdrostat Treatment Compared to Placebo in Participants With Uncontrolled Hypertension
- First Posted Date
- 2024-03-28
- Last Posted Date
- 2024-12-11
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 48
- Registration Number
- NCT06336356
- Locations
- 🇺🇸
Research Site, Norfolk, Virginia, United States
Efficacy of FDC Regimen of Dapagliflozin/Metformin Compared to Co-administered Dual Therapy on Glycemic Control, Satisfaction and Adherence in Chinese Patients With T2DM
- First Posted Date
- 2024-03-25
- Last Posted Date
- 2024-11-21
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 632
- Registration Number
- NCT06327815
- Locations
- 🇨🇳
Research Site, Zhuji, China
Assessment of Safety of Olaparib in Chinese Patients With Ovarian Cancer in the Real-World Setting
- First Posted Date
- 2024-03-22
- Last Posted Date
- 2024-08-07
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 2506
- Registration Number
- NCT06324734
- Locations
- 🇨🇳
Chinese Academy of Medical Sciences Cancer Hospital, Beijing, Beijing, China
Real-World Outcomes in COPD Patients Starting Trixeo (Budesonide/Glycopyrronium/Formoterol) in Spain.
Completed
- Conditions
- First Posted Date
- 2024-03-20
- Last Posted Date
- 2024-12-19
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 553
- Registration Number
- NCT06321731
- Locations
- 🇪🇸
Research Site, Zaragoza, Spain
INTERSTELLAR - International Study Evaluating Lupus Outcomes After Anifrolumab Real World Use
Not yet recruiting
- Conditions
- First Posted Date
- 2024-03-18
- Last Posted Date
- 2024-03-18
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 200
- Registration Number
- NCT06314282
A Study to Assess the Safety, Tolerability, and Pharmacokinetics of a Single Ascending Dose of AZD0292 In Healthy Participants
Phase 1
Active, not recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-03-15
- Last Posted Date
- 2024-12-05
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 17
- Registration Number
- NCT06311760
- Locations
- 🇺🇸
Research Site, Baltimore, Maryland, United States
Evaluating the Efficacy and Safety of PT027 Compared With PT007 Administered As Needed in Participants 12 to < 18 Years of Age With Asthma
Phase 3
Recruiting
- Conditions
- Interventions
- First Posted Date
- 2024-03-13
- Last Posted Date
- 2024-12-20
- Lead Sponsor
- AstraZeneca
- Target Recruit Count
- 440
- Registration Number
- NCT06307665
- Locations
- 🇿🇦
Research Site, Somerset West, South Africa
© Copyright 2024. All Rights Reserved by MedPath